Restless Legs Syndrome in Patients on Dialysis

American Journal of Kidney Diseases

Volumn 43, Issue 5, 2004, Pages 763-771

  Kavanagh, David ^b   Siddiqui, Samira ^b   Geddes, Colin C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b NONE

Author keywords

Dialysis; Dopamine; Hyperphosphatemia; Iron deficiency; Kidney failure; Levodopa (L dopa); Pathophysiology; Restless legs syndrome (RLS); Treatment; Uremia

Indexed keywords

AMANTADINE; BACLOFEN; BENSERAZIDE; BENZODIAZEPINE; CARBAMAZEPINE; CARBIDOPA; CLONAZEPAM; CLONIDINE; DECARBOXYLASE INHIBITOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ERYTHROPOIETIN; GABAPENTIN; IRON; KETAMINE; LEVODOPA; LITHIUM; OPIATE AGONIST; OXYCODONE; PERGOLIDE; PRAMIPEXOLE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANEMIA; BRAIN DYSFUNCTION; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DIAGNOSTIC APPROACH ROUTE; DIALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DIZZINESS; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DROWSINESS; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERPHOSPHATEMIA; INSOMNIA; IRON DEFICIENCY; IRON METABOLISM; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MEDICAL SOCIETY; MORTALITY; NAUSEA; NEUROIMAGING; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PSYCHOLOGICAL ASPECT; RESTLESS LEGS SYNDROME; REVIEW; RISK; SIDE EFFECT; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; UREMIA; XEROSTOMIA;

EID: 1942434761     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.01.007     Document Type: Review

References (105)

1. Allen RP, Hening W, Montplaisir J, et al: Restless legs syndrome (RLS), a common disorder rarely diagnosed in Europe or USA: The REST (RLS Epidemiology, Symptoms and Treatment) study in primary care. Mov Disord 17: S240A, 2002 (abstr, suppl 5)
2. Cooke B: The London Practice of Physick, Boston, MA p 104, Milford House, 1973
3. Winkelman JW: Restless legs syndrome. Arch Neurol 56:1526-1527, 1999
4. Chekhov A: The wedding proposal, in Garnett C (ed): The Russian. London, UK, Chatto & Windus, 1965, p 257
5. Ekbom K: Restless legs syndrome. Acta Med Scand 158:S4-S122, 1945 (suppl 1)
6. Ondo W, Jankovic J: Restless legs syndrome, in Appel S (ed): Current Neurology. The Netherlands, IOS, Amsterdam, 1997, pp 207-235
7. Allen RP, Earley CJ: Restless legs syndrome: A review of clinical and pathophysiologic features. J Clin Neurophysiol 18:128-147, 2001
8. Ondo W, Vuong K, Wang Q: Restless legs syndrome in monozygotic twins: Clinical correlates. Neurology 55:1404-1406, 2000
9. Desautels A, Turecki G, Montplaisir J, et al: Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 69:1266-1270, 2001
10. Bonati M, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G: Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 126:1485-1492, 2003
11. Desautels A, Turecki G, Montplaisir J, et al: Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 59:215-219, 2002
12. Filho G, Gorini C, Purysko A, Silva H, Elias I: Restless legs syndrome in patients on chronic hemodialysis in a Brazilian city: Frequency, biochemical findings and comorbidities. Arq Neuropsiquiatr 61:723-727, 2003
13. Miranda M, Araya F, Castillo J, Duran C, Gonzalez F, Aris L: Restless legs syndrome: A clinical study in adult general population and in uraemic patients. Rev Med Chil 129:179-186, 2001
14. Huiqi Q, Shan L, Mingcai Q: Restless legs syndrome (RLS) in uraemic patients is related to the frequency of haemodialysis sessions. Nephron 86:540, 2000
15. Hui D, Wong T, Ko F, et al: Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 36:783-788, 2000
16. Roger S, Harris D, Stewart J: Possible relation between restless legs and anaemia in renal dialysis patients. Lancet 337:1551, 1991
17. Walker S, Fine A, Kryger M: Sleep complaints are common in a dialysis unit. Am J Kidney Dis 26:751-758, 1995
18. Winkelman JW, Chertow GM, Lazarus JM: Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 28:372-378, 1996
19. Siddiqui S, Mak M, Kavanagh D, Geddes CC. Restless legs syndrome in haemodialysis patients. Presented at the Scottish Renal Association, May 9-10, 2003, Dumfries, Scotland.
20. Collad-Seidel V, Kohnen R, Samtleben W, Hillebrand G, Oertel W, Trenkwalder C: Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 31:324-328, 1998
21. Sabbatini M, Minale B, Crispo A, et al: Restless legs syndrome in maintenance haemodialysis patients. Nephrol Dial Transplant 17:852-856, 2002
22. Bhowmik D, Bhatia M, Gupta S, Agarwal S, Tiwari S, Dash S: Restless legs syndrome in haemodialysis patients in India: A case controlled study. Sleep Med 4:143-146, 2003
23. Takaki J, Nishi T, Nangaku M, et al: Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis 41:833-839, 2003
24. Walters AS: Towards a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10:634-642, 1995
25. Cirignotta F, Mondini S, Santoro A, Ferrari G, Gerardi R, Buzzi G: Reliability of a questionnaire screening restless legs syndrome in patients on chronic dialysis. Am J Kidney Dis 40:302-306, 2002
26. Kutner N, Bliwise D: Restless legs complaint in African-American and Caucasian hemodialysis patients. Sleep Med 3:497-500, 2002
27. De Vecchi A, Finazzi S, Padalino R, et al: Sleep disorders in peritoneal and haemodialysis patients as assessed by a self administered questionnaire. Int J Artif Organs 23:237-242, 2000
28. Winkelman JW, Chertow GM, Lagos L, et al: Restless legs syndrome is associated with reduced long term survival in patients with end stage renal disease. Presented at the 10th Annual Associated Professional Sleep Studies Meeting, June 1996, Washington, DC
29. Pressman M, Benz RL, Paterson D: Periodic leg movements in sleep index predicts mortality in end stage renal disease patients. Sleep Res 24:416A, 1995 (abstr)
30. Wetter T, Stiasny K, Kohnen R, Oertel W, Trenkwalder C: Polysomnographic sleep measures in patients with uraemic and idiopathic restless legs syndrome. Mov Disord 13:820-824, 1998
31. Winkelmann J, Wetter T, Collad-Seidel V, et al: Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 23:597-602, 2000
32. Allen RP, Picchietti D, Hening W, et al: Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 101-119, 2003
33. Montplaisir J, Boucher S, Poirer G, Lavigne G, Lapierre O, Lesperance P: Clinical, polysomnography and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria. Mov Disord 12:61-65, 1997
34. Akpinar S: Treatment of restless legs with levodopa plus benserazide. Arch Neurol 39:739, 1982
35. Montplaisir J, Godbout R, Poirer G, Bedard M: Restless legs syndrome and periodic movements in sleep; physiology and treatment with L-dopa. Clin Neuropharmacol 9:456-463, 1986
36. Winkelmann J, Schadrack J, Wetter T, Zieglgansberger W, Trenkwalder C: Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med 2:57-61, 2001
37. Staedt J, Stoppe G, Kogler A, et al: Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatr Clin Neurosci 245:8-10, 1995
38. Michaud M, Soucy J, Chabli A, et al: SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic limb movements in sleep. J Neurol 249:164-170, 2002
39. Turjanski N, Lees AJ, Brooks DJ: Striatal dopaminergic function in restless legs syndrome. Neurology 52:932-937, 1999
40. Tribl G, Asenbaum S, Klosch G, et al: Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome. Neurology 59:649-650, 2002
41. Eisensehr I, Wetter T, Linke R, et al: Normal IPT and IBZM SPECT in drug naive and levodopa- treated idiopathic restless legs syndrome. Neurology 57:1307-1309, 2001
42. Trenkwalder C, Walters AS, Hening W, et al: Positron emission tomographic studies in restless legs syndrome. Mov Disord 14:141-145, 1999
43. Turjanski N, Lees AJ, Brooks DJ: Dopaminergic dysfunction in patients with restless legs: (18F) Dopa and (1C) raclopride PET studies. Neurology 50:S391A, 1998 (suppl 4; abstr)
44. Ruottinen H, Partinen M, Hublin C, et al: An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 54:502-504, 2000
45. Briellmann R, Rosler K, Hess C: Blink reflex excitability is abnormal in patients with periodic leg movements in sleep. Mov Disord 11:710-714, 1996
46. Wechsler L, Stakes J, Shahani B, Busis N: Periodic leg movements of sleep (nocturnal myoclonus): An electro-physiological study. Ann Neurol 19:168-173, 1986
47. Bucher S, Seelos K, Oertel W, et al: Cerebral generators involved in the pathogenesis of restless legs syndrome. Ann Neurol 41:639-645, 1997
48. Bucher S, Trenkwalder C, Oertel W: Reflex studies and the MRI in the restless legs syndrome. Acta Med Scand 94:145-150, 1996
49. Chokroverty S: Editor's corner: Restless legs syndrome, a common disease uncommonly diagnosed. Sleep Med 4:91-93, 2003
50. Tergau F, Wischer S, Paulus W: Motor system excitability in patients with restless legs syndrome. Neurology 52:1060-1063, 1999
51. Entezari-Taher M, Singleton J, Jones C, et al: Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology 53:1201-1205, 1999
52. Bara-Jimenez W, Aksu M, Graham B, et al: Periodic limb movements in sleep: State-dependent excitability of the spinal flexor reflex. Neurology 54:1609-1616, 2000
53. Aksu M, Bara-Jimenez W: State dependent excitability changes of spinal flexor reflex in patients with restless legs syndrome secondary to chronic renal failure. Sleep Med 3:427-430, 2002
54. Fry J: Restless legs syndrome and periodic leg movements in sleep exacerbated or caused by minimal iron deficiency. Neurology 36:S276A, 1986 (suppl 1; abstr)
55. Matthews WB: Iron deficiency and restless legs. BMJ 1:898, 1976
56. Benz RL, Pressman MR, Hovick ET, Peterson DD: A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study). Am J Kidney Dis 34:1089-1095, 1999
57. O'Keeffe ST, Gavin K, Lavan JN: Iron status and restless legs syndrome in the elderly. Age Ageing 23:200-203, 1994
58. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP: Iron and the restless legs syndrome. Sleep 21:371-377, 1998
59. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP: Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54:1698-1700, 2000
60. Allen R, Barker P, Wehr F, Song H, Earley C: MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56:263-265, 2001
61. Connor JR, Boyer P, Menzies S, et al: Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 61:304-309, 2003
62. Richert A, Osuna E, Sateia M, Remillard B: A survey of sleep and restless legs in haemodialysis, peritoneal dialysis and renal transplant populations. Sleep 21:S91A, 1998 (suppl 1; abstr)
63. Garvey M, Tollefson G: Occurrence of myoclonus in patients treated with tricyclic antidepressants. Arch Gen Psychiatry 44:269-272, 1987
64. Bakshi R: Fluoxetine and restless legs syndrome. J Neurol Sci 142:151-152, 1996
65. Terao T, Terao M, Yoshimura R, Abe K: Restless legs syndrome induced by lithium. Biol Psychiatry 30:1167-1170, 1991
66. Dimmit S, Riley G: Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms. Arch Intern Med 160:712-715, 2000
67. Kerr PG, van Bakel C, Dawborn JK: Assessment of the symptomatic benefit of cool dialysate. Nephron 52:166-169, 1989
68. Davis B, Rajput A, Rajput M, Aul E, Eichhorn G: A randomised double blind placebo controlled trial of iron restless legs syndrome. Eur J Neurosci 43:70-75, 1998
69. Norlander N: Restless legs. Br J Phys Med 17:160-162, 1954
70. Akpinar S: Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol 10:69-79, 1987
71. Von Scheele C: Levodopa in restless legs. Lancet 2:426-427, 1986
72. Brodeur C, Montplaisir J, Godbout R, Marinier R: Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: A double blind controlled trial. Neurology 38:1845-1848, 1988
73. Trenkwalder C, Stiasny K, Pollmacher T, et al: L-Dopa therapy of uraemic and idiopathic restless legs syndrome: Double blind, crossover trial. Sleep 18:681-688, 1995
74. Sandyk R, Bernick C, Lee S, Stern L, Iacono R, Bamford C: L-Dopa in uraemic patients with the restless legs syndrome. Int J Neurosci 35:233-235, 1987
75. Walker S, Fine A, Kryger M: L-Dopa/carbidopa for nocturnal movement disorders in uraemia. Sleep 19:214-218, 1996
76. Earley CJ, Allen RP: Pergolide and carbidopa/levodpa treatment of restless legs syndrome and periodic leg movements in a consecutive series of patients. Sleep 19:801-810, 1996
77. Allen RP, Earley CJ: Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19:205-213, 1996
78. Wetter T, Stiasny K, Winkelman JW, et al: A randomised controlled study of pergolide in patients with restless legs syndrome. Neurology 52:944-950, 1999
79. Silber M, Shepard J, Wisbey J: Pergolide in the management of restless legs syndrome: An extended study. Sleep 20:878-882, 1997
80. Earley CJ, Yaffee J, Allen RP: Randomised, double-blind controlled trial of pergolide in restless legs syndrome. Neurology 51:1599-1602, 1998
81. Trenkwalder C, Brandenburg U, Hundemer H, et al: A randomised long-term placebo controlled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data. Neurology 56:S5A, 2001 (suppl 3; abstr)
82. Montplaisir J, Nicolas A, Denesle R, Gomez-Mancilla B: Restless legs syndrome improved by pramipexole: A double blind randomised controlled trial. Neurology 52:938-943, 1999
83. Ondo W: Ropinirole for restless legs syndrome. Mov Disord 14:138-140, 1999
84. Pieta J, Millar T, Zacharias J, Fine A, Kryger M: Effect of pergolide on restless legs and leg movements in sleep in uraemic patients. Sleep 21:617-622, 1998
85. Staedt J, Wabmuth F, Ziemann U, Hajak G, Ruther E, Stoppe G: Pergolide: Treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double blind randomized crossover trial of pergolide versus L-dopa. J Neural Transm 104:461-468, 1997
86. Staedt J, Hunerjager H, Ruther E, Stoppe G: Pergolide: Treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS): Long term follow up on pergolide. J Neural Transm 105:265-268, 1998
87. Stiasny K, Wetter T, Winkelman JW, et al: Long term effects of pergolide in the treatment of restless legs syndrome. Neurology 56:1399-1402, 2001
88. Hening W, Allen RP, Earley CJ, Kushida C, Picchietti D, Silber M: The treatment of restless legs syndrome and periodic limb movement disorder: An American Academy of Sleep Medicine review. Sleep 22:970-999, 1999
89. Walters AS, Wagner M, Hening W, et al: Successful treatment of the idiopathic restless legs syndrome in a randomised double blind trial of oxycodone versus placebo. Sleep 16:327-332, 1993
90. Boghen D, Lamothe L, Elie R, Godbout R, Montplaisir J: The treatment of the restless legs syndrome with clonazepam: A prospective controlled study. Can J Neurol Sci 13:245-247, 1986
91. Montagna P, Sassoli de Bianchi L, Zucconi M, Cirignotta F, Lugaresi E: Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 69:428-430, 1984
92. Schenck CH, Mahowald MW: Long term, benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 100:333-337, 1996
93. Read DJ, Feest TG, Nassim MA: Clonazepam: Effective treatment for restless legs syndrome in uraemia. BMJ 283:885-886, 1981
94. Telstad W, Sorensen O, Larsen S, Lillevold P, Stensrud P, Nyberg-Hansen R: Treatment of restless legs syndrome with carbemazepine: A double blind study. BMJ 288:444-446, 1984
95. Adler C: Treatment of restless legs syndrome with gabapentin. Clin Neuropharmacol 20:148-151, 1997
96. Mellick GA, Mellick LB: Management of restless legs syndrome with gabapentin. Sleep 19:224-226, 1996
97. Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G: Treatment of restless legs syndrome with gabapentin. A double blind, cross over study. Neurology 59:1573-1579, 2002
98. Thorp M, Morris C, Bagby S: A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis 38:104-108, 2001
99. Wagner M, Walters AS, Coleman R, Hening W, Grasing K, Chokroverty S: Randomised double blind placebo controlled study of clonidine in restless legs syndrome. Sleep 19:52-58, 1996
100. Ausserwinkler M, Schimdt P: Successful clonidine treatment of restless legs syndrome in chronic kidney insufficiency. Schweiz Med Wochenschr 119:184-186, 1989
101. Evidente V, Adler C, Caviness J, Hentz J, Gwinn-Hardy K: Amantadine is beneficial in restless legs syndrome. Mov Disord 15:324-327, 2000
102. Guilleminault C, Flagg W: Effect of baclofen on sleep related periodic movements. Ann Neurol 15:234-239, 1984
103. Kapur N, Friedman R: Oral ketamine: A promising treatment for restless legs syndrome. Anesth Analg 94:1558-1559, 2002
104. Yasuda T, Nishimura A, Katsuki Y, Tsuji Y: Restless legs syndrome treated successfully by kidney transplantation-A case report. Clin Transpl 1986:138, 1986
105. Winkelmann JW, Stautner A, Samtleben W, Trenkwalder C: Long term course of restless legs syndrome in dialysis patients after kidney transplantation. Mov Disord 17:1072-1076, 2002